Literature DB >> 27093160

Pneumocystis Jirovecii Pneumonia in a Patient with Anti-N-Methyl-D-Aspartate Receptor Postherpetic Encephalitis.

Jorge García-Moreno1, Jon Igartua Laraudogoitia, Milagrosa Montes Ros.   

Abstract

Anti-N-methyl-D-aspartate receptor encephalitis is a neuroimmunologic disorder that has been increasingly diagnosed during the past 5 years. It provokes a predictable syndrome treated with several immunomodulatory agents, such as corticosteroids and/or biologics. We managed a child with this disease who developed Pneumocystis jirovecii pneumonia as a direct infectious complication of the use of rituximab.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27093160     DOI: 10.1097/INF.0000000000001165

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  2 in total

1.  Pneumocystis Pneumonia during Rituximab Treatment in Children with Autoimmune Nerve System Diseases.

Authors:  Ji Zhou; Yao Zhang; Yiwen Jin; Taoyun Ji; Xinhua Bao; Yuehua Zhang; Hui Xiong; Xinzhi Chang; Yuwu Jiang; Ye Wu
Journal:  J Neuroimmune Pharmacol       Date:  2018-05-17       Impact factor: 4.147

2.  Pneumocystis jirovecii Pneumonia in Neurologic Disorders: Is Prophylaxis Necessary?

Authors:  Tiffany Pike-Lee; Sana Syed; Mary Alissa Willis; Yuebing Li
Journal:  Neurol Clin Pract       Date:  2021-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.